FDA Approves Genentech’s Susvimo for Wet AMD

October 29, 2021

Category: FDA, Regulations

Genentech, a member of the Roche Group, announced on Oct. 22nd, 2021, that FDA had approved Susvimo (100 mg/mL ranibizumab injection) for the treatment of wet, or neovascular, age-related macular degeneration (AMD), a condition that can lead to rapid and […]

Novartis inks deal to manufacture Pfizer COVID-19 vaccines in Slovenia

October 21, 2021

Novartis inked an agreement that could see production of the Pfizer-BioNTech COVID-19 vaccine move from its facility in Switzerland to its fill-finish plant in Ljubljana, Slovenia. Under the initial agreement, Novartis would get bulk mRNA active ingredients from BioNTech, fill […]

Spark to use CombiGene therapy to target focal epilepsy

October 13, 2021

Spark Therapeutics has secured the exclusive rights to CombiGene’s CG01 therapy, which aims to treat drug resistant focal epilepsy, in a deal worth $8.5m in advance with further payments due on reaching clinical milestones. The news sent Swedish firm CombiGene’s […]

Industry, Vaccines

Sanofi to acquire Origimm Biotechnology to develop acne vaccine

December 2, 2021

Via: European Pharmaceutical Review

Sanofi has announced that it entered into an agreement to acquire Origimm Biotechnology, an Austrian privately owned biotechnology company specialising in the discovery of virulent skin microbiome components and antigens from bacteria causing skin disease, such as acne. The transaction […]

Cell and Gene Therapy, Industry

Dyno attracts $1.6bn gene therapy deal with Astellas

December 2, 2021

Via: Pharmaphorum

The Japanese drugmaker is paying $18 million upfront to exercise an option on the AAV platform – which my help avoid safety issues that have emerged with other AAV-based gene therapies – with milestone and royalty payments that could exceed […]


AWS helps Pfizer accelerate drug development and clinical manufacturing

December 2, 2021

Via: World Pharma News

Today, Amazon Web Services, Inc. (AWS), an, Inc. company (NASDAQ: AMZN), announced that it is working with Pfizer to create innovative, cloud-based solutions with the potential to improve how new medicines are developed, manufactured, and distributed for testing in […]

Mergers and Acquisitions

Get ready for M&A: Large biopharma companies will have $1.7T in dealmaking firepower next year, analyst says

December 1, 2021

Via: FiercePharma

Merger and acquisition activity has been rather slow in the biopharma industry so far this year. But, by one team of analysts’ calculations, large drugmakers will have big piles of cash to deploy in 2022. Eighteen large-cap U.S. and European […]

Cell and Gene Therapy, Industry

J&J cell therapy head exits to take up post at fledgling biotech

December 1, 2021

Via: FierceBiotech

Johnson & Johnson has lost its global head, cell therapy platform and discovery. Tamas Oravecz, Ph.D., took up the post at J&J’s Janssen earlier this year, only to leave to become chief scientific officer at the newly minted cancer biotech […]

Industry, Vaccines

Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response

December 1, 2021

Via: World Pharma News

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of […]